Skip to main content
. 2026 Jun 27;14(7):231. doi: 10.3390/diseases14070231
ALT Alanine Aminotransferase
ASCO American Society of Clinical Oncology
AST Aspartate Aminotransferase
BSA Body Surface Area
CCR Complete Control Rate
CI Confidence Interval
CINV Chemotherapy-induced Nausea and Vomiting
CRR the complete response rate
CTCAE the Common Terminology Criteria for Adverse Events
DEX Dexamethasone
ECG Electrocardiogram
ECOG Eastern Cooperative Oncology Group
ESMO European Society for Medical Oncology
HEC Highly Emetogenic Chemotherapy
MASCC Multinational Association of Supportive Care in Cancer
MEC Moderately Emetogenic Chemotherapy
mITT the modified intention-to-treat population
NCCN National Comprehensive Cancer Network
NEPA Netupitant-Palonoseton
NK-1 RA NK-1 receptor antagonist
PPS Per-protocol Set
QTcB QT interval corrected by Bazett’s formula
RCT Randomized Controlled Trial
SAE Serious Adverse Event
TCR Total Control Rate
TRAE Treatment-Related Adverse Event
5-HT3 5-hydroxytryptamine-3